Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · IEX Real-Time Price · USD
10.50
+0.07 (0.67%)
May 2, 2024, 11:15 AM EDT - Market open
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees on December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$772,449
Profits / Employee
-$293,199
Market Cap
3.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 517 | 33 | 6.82% |
Dec 31, 2022 | 484 | -12 | -2.42% |
Dec 31, 2021 | 496 | 13 | 2.69% |
Dec 31, 2020 | 483 | -101 | -17.29% |
Dec 31, 2019 | 584 | 76 | 14.96% |
Dec 31, 2018 | 508 | 183 | 56.31% |
Dec 31, 2017 | 325 | 62 | 23.57% |
Dec 31, 2016 | 263 | 78 | 42.16% |
Dec 31, 2015 | 185 | 88 | 90.72% |
Dec 31, 2014 | 97 | 5 | 5.43% |
Dec 31, 2013 | 92 | -20 | -17.86% |
Dec 31, 2012 | 112 | 16 | 16.67% |
Dec 31, 2011 | 96 | -3 | -3.03% |
Dec 31, 2010 | 99 | 2 | 2.06% |
Dec 31, 2009 | 97 | -18 | -15.65% |
Dec 31, 2008 | 115 | 24 | 26.37% |
Dec 31, 2007 | 91 | 14 | 18.18% |
Dec 31, 2006 | 77 | 25 | 48.08% |
Dec 31, 2005 | 52 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
Azenta | 3,500 |
LivaNova | 2,900 |
Olink Holding AB (publ) | 707 |
TransMedics Group | 584 |
Immunocore Holdings | 497 |
Xenon Pharmaceuticals | 259 |
IDEAYA Biosciences | 124 |
FOLD News
- 1 day ago - Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report - GlobeNewsWire
- 2 months ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 - GlobeNewsWire
- 2 months ago - Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates - GlobeNewsWire
- 2 months ago - Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 3 months ago - Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™ - GlobeNewsWire
- 3 months ago - Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024 - GlobeNewsWire
- 4 months ago - Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook - GlobeNewsWire